Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02191033 · ClinicalTrials.gov registry record · NA
Text Messaging for Smoking Cessation in College Health Clinics
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02191033 is a NA study that has completed, run by Yale University. The registered enrollment target is 40 participants.
The verdict
NCT02191033, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is a randomized-controlled clinical trial which evaluates the efficacy of physician brief advice, nicotine replacement therapy and a 6-week course of text messaging in promoting cigarette smoking in smokers enrolled in college. The primary hypothesis is that smokers receiving physician brief advice, nicotine replacement therapy, and text messaging will have higher quit rates that smokers receiving physician brief advice and nicotine replacement therapy alone.
Interventions
- DRUG Nicotine patch
- BEHAVIORAL Text messaging
- BEHAVIORAL Smoking counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02191033
The ClinicalTrials.gov registry entry for NCT02191033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine patch is the first listed.
NCT02191033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02191033 about?
NCT02191033 is a clinical study titled "Text Messaging for Smoking Cessation in College Health Clinics". This study is a randomized-controlled clinical trial which evaluates the efficacy of physician brief advice, nicotine replacement therapy and a 6-week course of text messaging in promoting cigarette smoking in smokers enrolled in college. The primary hypothesis is that smokers receiving physician b...
What is the current status of trial NCT02191033?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2015-01. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02191033?
The interventions under investigation include: Nicotine patch (DRUG), Text messaging (BEHAVIORAL), Smoking counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02191033?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.